Antisickling Drugs Targeting βCys93 Reduce Iron Oxidation and Oxidative Changes in Sickle Cell Hemoglobin

Frontiers in Physiology - Switzerland
doi 10.3389/fphys.2019.00931
Full Text
Abstract

Available in full text

Categories
Physiology
Date
Authors
Publisher

Frontiers Media SA

Related search

Dichloromethane as an Antisickling Agent in Sickle Cell Hemoglobin.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1976English

Substitutions in the Β Subunits of Sickle-Cell Hemoglobin Improve Oxidative Stability and Increase the Delay Time of Sickle-Cell Fiber Formation

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2019English

Sickle Cell-Hemoglobin C Disease Syndrome

2020English

Genetic Variants and Cell-Free Hemoglobin Processing in Sickle Cell Nephropathy

Haematologica
Hematology
2015English

Elevated Soluble Α-Hemoglobin Pool in Sickle Cell Anemia

American Journal of Hematology
Hematology
2017English

Free Heme and the Polymerization of Sickle Cell Hemoglobin

Biophysical Journal
Biophysics
2010English

Hydroxyurea Enhances Fetal Hemoglobin Production in Sickle Cell Anemia.

Journal of Clinical Investigation
Medicine
1984English

Sickle-Cell Hemoglobin: Fall in Osmotic Pressure Upon Deoxygenation.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1980English

Emerging Drugs for Sickle Cell Anemia

Expert Opinion on Emerging Drugs
Pharmacology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy